Actinium Pharmaceuticals, Inc.
ATNM$44M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaNEW YORK25 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
ATNM News
Catalyst Timeline
0 upcoming, 0 past
No catalysts found.
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Iomab-B | Phase 3 | Acute Myeloid Leukemia | - | - |
Cytarabine (Phase 1 only) | Phase 2 | AML | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply